Axsome Therapeutics (AXSM) EPS (Basic) (2015 - 2026)
Axsome Therapeutics (AXSM) posted EPS (Basic) of -$1.26 for Q1 2026, down 119.04% sequentially from -$0.58 in Q4 2025, and down 3.69% YoY from -$1.31 in Q1 2025.
Powered by 
Analysis
Axsome Therapeutics (AXSM) EPS (Basic) (2015 - 2026) Analysis & Trends
Axsome Therapeutics has reported EPS (Basic) for 12 years, with the latest figure at -$1.26 in Q1 2026.
- Quarterly EPS (Basic) fell 3.69% year-over-year to -$1.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.68 (up 35.38% YoY) and the FY2025 annual result came in at -$3.68, up 38.56% from the prior year.
- EPS (Basic) slipped to -$1.26 in Q1 2026 per AXSM's latest filing, from -$0.58 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.26 in Q1 2023 and troughed at -$2.17 in Q4 2023.
- A 5-year average of -$1.23 and a median of -$1.26 in 2026 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) surged 81.76% in 2022, then sank 458.6% in 2024.
- Over 5 years, EPS (Basic) stood at -$1.51 in 2022, then sank by 44.15% to -$2.17 in 2023, then rose by 28.0% to -$1.56 in 2024, then jumped by 63.19% to -$0.58 in 2025, then plunged by 119.04% to -$1.26 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.26, -$0.58, and -$0.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 0.18 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.06 |
| 10 | Axsome Therapeutics | 10.73 Bn | 10.41 Bn | 204.81 Mn | -0.99 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.99 |
| Mar 31, 2026 | -1.26 |
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | -0.94 |
| Jun 30, 2025 | -0.97 |
| Mar 31, 2025 | -1.22 |
| Dec 31, 2024 | -1.56 |
| Sep 30, 2024 | -1.34 |
| Jun 30, 2024 | -1.67 |
| Mar 31, 2024 | -1.44 |
| Dec 31, 2023 | -2.17 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -1.54 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | -1.51 |
| Sep 30, 2022 | -1.07 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -1.03 |
| Dec 31, 2021 | -0.90 |
| Sep 30, 2021 | -0.93 |